Open Access68Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer
Author(s) -
Quetzali Pitalúa-Cortés,
Francisco GarcíaPérez,
Yolanda VillaseñorNavarro,
Fernando LaraMedina,
Juan Matus-Santos,
Irma Soldevilla-Gallardo,
Fany Iris Porras-Reyes,
Víctor M. Pérez-Sánchez,
Héctor Aquiles Maldonado-Martínez,
Wendy B. Pérez-Báez,
Isabel Sollozo-Dupont
Publication year - 2017
Publication title -
bjr case reports
Language(s) - English
Resource type - Journals
ISSN - 2055-7159
DOI - 10.1259/bjrcr.20160136
Subject(s) - positron emission tomography , epidermal growth factor receptor , human epidermal growth factor receptor 2 , breast cancer , epidermal growth factor , cancer research , lung cancer , medicine , cancer , pathology , nuclear medicine , molecular imaging , receptor , oncology , biology , in vivo , microbiology and biotechnology
Molecular identification of a metastatic tumour without the inconvenience of a biopsy and the time required for pathological characterization is possible using molecular imaging. Here, we present the case of a patient with breast cancer in whom 68 Ga-diethylenetriamine pentaacetic acid anti-human epidermal growth factor receptor 2 positron emission tomography-CT was successfully employed to characterize the expression of human epidermal growth factor receptor 2 in metastatic sites.